Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 10, Issue 18
15 September 2004
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265

Editorial

Is the Gene Expression Pattern of Lung Cancer Detected by Screening With Spiral Computed Tomography Different from That of Symptom-Detected Lung Cancer?
James L. Mulshine; John N. Weinstein
View articletitled, Is the Gene Expression Pattern of Lung Cancer Detected by Screening With Spiral Computed Tomography Different from That of Symptom-Detected Lung Cancer?
Open the PDF for in another window

Featured Articles

Molecular Oncology, Markers, Clinical Correlates
Truncating BRCA1 Mutations Are Uncommon in a Cohort of Hereditary Prostate Cancer Families with Evidence of Linkage to 17q Markers
Kimberly A. Zuhlke; Jennifer J. Madeoy; Jennifer Beebe-Dimmer; Kirsten A. White; Angela Griffin; Ethan M. Lange; Stephen B. Gruber; Elaine A. Ostrander; Kathleen A. Cooney
View articletitled, Truncating <strong><em>BRCA1</em></strong> Mutations Are Uncommon in a Cohort of Hereditary Prostate Cancer Families with Evidence of Linkage to 17q Markers
Open the PDF for in another window
Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non–Small Cell Lung Cancer
Stefan Holdenrieder; Petra Stieber; Joachim von Pawel; Hannelore Raith; Dorothea Nagel; Knut Feldmann; Dietrich Seidel
View articletitled, Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for in another window
Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes
Chris Jones; Emily Ford; Cheryl Gillett; Ken Ryder; Samantha Merrett; Jorge S. Reis-Filho; Laura G. Fulford; Andrew Hanby; Sunil R. Lakhani
View articletitled, Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes
Supplementary data
Open the PDF for in another window
Hypermethylation in Histologically Distinct Classes of Breast Cancer
Young Kyung Bae; Amy Brown; Elizabeth Garrett; Daniel Bornman; Mary Jo Fackler; Saraswati Sukumar; James G. Herman; Edward Gabrielson
View articletitled, Hypermethylation in Histologically Distinct Classes of Breast Cancer
Open the PDF for in another window
Effects of Gefitinib on Serum Epidermal Growth Factor Receptor and HER2 in Patients with Advanced Non-Small Cell Lung Cancer
Vanesa Gregorc; Giovanni Luca Ceresoli; Irene Floriani; Anna Spreafico; Katia Bruna Bencardino; Vienna Ludovini; Lorenza Pistola; Zhasmina Mihaylova; Francesca Romana Tofanetti; Massimiliano Ferraldeschi; Valter Torri; Federico Cappuzzo; Lucio Crinò; Maurizio Tonato; Eugenio Villa
View articletitled, Effects of Gefitinib on Serum Epidermal Growth Factor Receptor and HER2 in Patients with Advanced Non-Small Cell Lung Cancer
Open the PDF for in another window
Comprehensive Characterization of Annexin I Alterations in Esophageal Squamous Cell Carcinoma
Nan Hu; Michael J. Flaig; Hua Su; Jian-Zhong Shou; Mark J. Roth; Wen-Jun Li; Chaoyu Wang; Alisa M. Goldstein; Guang Li; Michael R. Emmert-Buck; Philip R. Taylor
View articletitled, Comprehensive Characterization of <strong><em>Annexin I</em></strong> Alterations in Esophageal Squamous Cell Carcinoma
Open the PDF for in another window
Lung Cancers Detected by Screening with Spiral Computed Tomography Have a Malignant Phenotype when Analyzed by cDNA Microarray
Fabrizio Bianchi; Jiangting Hu; Giuseppe Pelosi; Rosalia Cirincione; Mary Ferguson; Cathy Ratcliffe; Pier Paolo Di Fiore; Kevin Gatter; Francesco Pezzella; Ugo Pastorino
View articletitled, Lung Cancers Detected by Screening with Spiral Computed Tomography Have a Malignant Phenotype when Analyzed by cDNA Microarray
Open the PDF for in another window
Molecular Prediction of Response to 5-Fluorouracil and Interferon-α Combination Chemotherapy in Advanced Hepatocellular Carcinoma
Yukinori Kurokawa; Ryo Matoba; Hiroaki Nagano; Masato Sakon; Ichiro Takemasa; Shoji Nakamori; Keizo Dono; Koji Umeshita; Noriko Ueno; Shin Ishii; Kikuya Kato; Morito Monden
View articletitled, Molecular Prediction of Response to 5-Fluorouracil and Interferon-α Combination Chemotherapy in Advanced Hepatocellular Carcinoma
Open the PDF for in another window
Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer
Pier Francesco Ferrucci; Cristina Rabascio; Chiara Mazzetta; Emilia Cocorocchio; Alberto Agazzi; Anna Vanazzi; Saverio Cinieri; Fedro A. Peccatori; Mara Paolucci; Francesco Bertolini; Giovanni Martinelli
View articletitled, Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer
Open the PDF for in another window
Identification of a Novel Human Cancer/Testis Antigen, KM-HN-1, Recognized by Cellular and Humoral Immune Responses
Mikio Monji; Tetsuya Nakatsura; Satoru Senju; Yoshihiro Yoshitake; Motohiro Sawatsubashi; Masanori Shinohara; Toshiro Kageshita; Tomomichi Ono; Akira Inokuchi; Yasuharu Nishimura
View articletitled, Identification of a Novel Human Cancer/Testis Antigen, KM-HN-1, Recognized by Cellular and Humoral Immune Responses
Open the PDF for in another window
Experimental Therapeutics, Preclinical Pharmacology
Low-Dose Suramin Enhanced Paclitaxel Activity in Chemotherapy-Naïve and Paclitaxel-Pretreated Human Breast Xenograft Tumors
SaeHeum Song; Bei Yu; Yong Wei; M. Guillaume Wientjes; Jessie L.-S. Au
View articletitled, Low-Dose Suramin Enhanced Paclitaxel Activity in Chemotherapy-Naïve and Paclitaxel-Pretreated Human Breast Xenograft Tumors
Open the PDF for in another window
Enhancement of Xenograft Tumor Radiosensitivity by the Histone Deacetylase Inhibitor MS-275 and Correlation with Histone Hyperacetylation
Kevin Camphausen; Tamalee Scott; Mary Sproull; Philip J. Tofilon
View articletitled, Enhancement of Xenograft Tumor Radiosensitivity by the Histone Deacetylase Inhibitor MS-275 and Correlation with Histone Hyperacetylation
Open the PDF for in another window

Regular Articles

Clinical Trials
Cyclophosphamide Dose Intensification during Induction Therapy for Intermediate-Risk Pediatric Rhabdomyosarcoma Is Feasible but Does Not Improve Outcome: A Report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group
Sheri L. Spunt; Lynette M. Smith; Frederick B. Ruymann; Stephen J. Qualman; Sarah S. Donaldson; David A. Rodeberg; James R. Anderson; William M. Crist; Michael P. Link
View articletitled, Cyclophosphamide Dose Intensification during Induction Therapy for Intermediate-Risk Pediatric Rhabdomyosarcoma Is Feasible but Does Not Improve Outcome<span class="subtitle-colon">: </span><span class="subtitle">A Report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group</span>
Open the PDF for in another window
Sequential Intraperitoneal Topotecan and Oral Etoposide Chemotherapy in Recurrent Platinum-Resistant Ovarian Carcinoma: Results of a Phase II Trial
Anil K. Sood; Richard Lush; John P. Geisler; Mark S. Shahin; Linda Sanders; Dan Sullivan; Richard E. Buller; Joel I. Sorosky
View articletitled, Sequential Intraperitoneal Topotecan and Oral Etoposide Chemotherapy in Recurrent Platinum-Resistant Ovarian Carcinoma<span class="subtitle-colon">: </span><span class="subtitle">Results of a Phase II Trial</span>
Open the PDF for in another window
A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C-α, in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non–Small Cell Lung Cancer
Miguel A. Villalona-Calero; Paul Ritch; Jose A. Figueroa; Gregory A. Otterson; Robert Belt; Edward Dow; Sebastian George; James Leonardo; Spence McCachren; G. Lance Miller; Manuel Modiano; Manuel Valdivieso; Richard Geary; Jennifer W. Oliver; Jon Holmlund
View articletitled, A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C-α, in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for in another window
Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin
Lee M. Krug; Govind Ragupathi; Chandra Hood; Mark G. Kris; Vincent A. Miller; Jennifer R. Allen; Stacy J. Keding; Samuel J. Danishefsky; Jorge Gomez; Leslie Tyson; Barbara Pizzo; Valerie Baez; Philip O. Livingston
View articletitled, Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin
Open the PDF for in another window
Combination Immunotherapy of B-Cell Non-Hodgkin’s Lymphoma with Rituximab and Interleukin-2: A Preclinical and Phase I Study
Charles F. Eisenbeis; Andrew Grainger; Beth Fischer; Robert A. Baiocchi; Lester Carrodeguas; Sameek Roychowdhury; Lei Chen; Amy L. Banks; Thomas Davis; Donn Young; Nicole Kelbick; Julie Stephens; John C. Byrd; Michael R. Grever; Michael A. Caligiuri; Pierluigi Porcu
View articletitled, Combination Immunotherapy of B-Cell Non-Hodgkin’s Lymphoma with Rituximab and Interleukin-2<span class="subtitle-colon">: </span><span class="subtitle">A Preclinical and Phase I Study</span>
Open the PDF for in another window
Phase II Study of the Proteasome Inhibitor Bortezomib (PS-341) in Patients with Metastatic Neuroendocrine Tumors
Manisha H. Shah; Donn Young; Hedy L. Kindler; Iain Webb; Barbara Kleiber; John Wright; Michael Grever
View articletitled, Phase II Study of the Proteasome Inhibitor Bortezomib (PS-341) in Patients with Metastatic Neuroendocrine Tumors
Open the PDF for in another window

Research Articles

Molecular Oncology, Markers, Clinical Correlates
Value of p16INK4a and RASSF1A Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung Cancer
Jie Wang; J. Jack Lee; Luo Wang; Diane D. Liu; Charles Lu; You-Hong Fan; Waun Ki Hong; Li Mao
View articletitled, Value of <strong><em>p16</em></strong><sup>INK4a</sup> and <strong><em>RASSF1A</em></strong> Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung Cancer
Open the PDF for in another window
Aberrant Promoter Hypermethylation of Multiple Genes in Gallbladder Carcinoma and Chronic Cholecystitis
Takao Takahashi; Narayan Shivapurkar; Erick Riquelme; Hisayuki Shigematsu; Jyotsna Reddy; Makoto Suzuki; Kuniharu Miyajima; Xian Zhou; B. Nebiyou Bekele; Adi F. Gazdar; Ignacio I. Wistuba
View articletitled, Aberrant Promoter Hypermethylation of Multiple Genes in Gallbladder Carcinoma and Chronic Cholecystitis
Open the PDF for in another window
Overexpression of the Nuclear Receptor Coactivator AIB1 (SRC-3) during Progression of Pancreatic Adenocarcinoma
Ralf Thorsten Henke; Bassem R. Haddad; Sung Eun Kim; Janice Dalby Rone; Aparna Mani; John Milburn Jessup; Anton Wellstein; Anirban Maitra; Anna Tate Riegel
View articletitled, Overexpression of the Nuclear Receptor Coactivator <strong><em>AIB1</em></strong> (<strong><em>SRC-3</em></strong>) during Progression of Pancreatic Adenocarcinoma
Open the PDF for in another window
Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma
Nikita A. Makretsov; David G. Huntsman; Torsten O. Nielsen; Erika Yorida; Michael Peacock; Maggie C. U. Cheang; Sandra E. Dunn; Malcolm Hayes; Matt van de Rijn; Chris Bajdik; C. Blake Gilks
View articletitled, Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma
Open the PDF for in another window
Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates with Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms
Donna E. Hansel; Ayman Rahman; Michael House; Raheela Ashfaq; Karin Berg; Charles J. Yeo; Anirban Maitra
View articletitled, Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates with Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms
Open the PDF for in another window
Characterization of Mutator Phenotype in Familial Colorectal Cancer Patients Not Fulfilling Amsterdam Criteria
Jin C. Kim; Kang H. Lee; In H. Ka; Kum H. Koo; Seon A. Roh; Hee C. Kim; Chang S. Yu; Tae W. Kim; Heung M. Chang; Gyeong Y. Gong; Jung S. Kim
View articletitled, Characterization of Mutator Phenotype in Familial Colorectal Cancer Patients Not Fulfilling Amsterdam Criteria
Open the PDF for in another window
The Fibroblast Growth Factor Receptor-4 Arg388 Allele Is Associated with Prostate Cancer Initiation and Progression
Jianghua Wang; David W. Stockton; Michael Ittmann
View articletitled, The Fibroblast Growth Factor Receptor-4 Arg<sup>388</sup> Allele Is Associated with Prostate Cancer Initiation and Progression
Open the PDF for in another window
The Antimetastatic Role of Thrombomodulin Expression in Islet Cell-Derived Tumors and Its Diagnostic Value
Satoshi Iino; Kazuhiro Abeyama; Ko-ichi Kawahara; Munekazu Yamakuchi; Teruto Hashiguchi; Sumika Matsukita; Suguru Yonezawa; Shotaro Taniguchi; Masanori Nakata; Sonshin Takao; Takashi Aikou; Ikuro Maruyama
View articletitled, The Antimetastatic Role of Thrombomodulin Expression in Islet Cell-Derived Tumors and Its Diagnostic Value
Open the PDF for in another window
Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients
Essel Dulaimi; Jeanne Hillinck; Inmaculada Ibanez de Caceres; Tahseen Al-Saleem; Paul Cairns
View articletitled, Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients
Open the PDF for in another window
The Prognostic Value of BCAR1 in Patients with Primary Breast Cancer
Lambert C. J. Dorssers; Nicolai Grebenchtchikov; Arend Brinkman; Maxime P. Look; Simone P. J. van Broekhoven; Danielle de Jong; Harry A. Peters; Henk Portengen; Marion E. Meijer-van Gelder; Jan G. M. Klijn; Doorlene T. H. van Tienoven; Anneke Geurts-Moespot; Paul N. Span; John A. Foekens; Fred C. G. J. Sweep
View articletitled, The Prognostic Value of BCAR1 in Patients with Primary Breast Cancer
Open the PDF for in another window
Expression of Uncoupling Protein-2 in Human Colon Cancer
Masayoshi Horimoto; Murray B. Resnick; Tamako A. Konkin; Justin Routhier; Jack R. Wands; György Baffy
View articletitled, Expression of Uncoupling Protein-2 in Human Colon Cancer
Open the PDF for in another window
Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma: A Meta-Analysis
Emilios E. Pakos; Panayiotis A. Kyzas; John P. A. Ioannidis
View articletitled, Prognostic Significance of <strong><em>TP53</em></strong> Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma<span class="subtitle-colon">: </span><span class="subtitle">A Meta-Analysis</span>
Open the PDF for in another window
p53 Expression as a Prognostic Marker in Inflammatory Breast Cancer
Ana M. Gonzalez-Angulo; Nour Sneige; Aman U. Buzdar; Vicente Valero; Shu-Wan Kau; Kristine Broglio; Yuko Yamamura; Gabriel N. Hortobagyi; Massimo Cristofanilli
View articletitled, p53 Expression as a Prognostic Marker in Inflammatory Breast Cancer
Open the PDF for in another window
Experimental Therapeutics, Preclinical Pharmacology
Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option
William P. J. Leenders; Benno Küsters; Kiek Verrijp; Cathy Maass; Pieter Wesseling; Arend Heerschap; Dirk Ruiter; Andy Ryan; Robert de Waal
View articletitled, Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option
Open the PDF for in another window
Analysis of Antitumor Activity of an Interleukin-13 (IL-13) Receptor-Targeted Cytotoxin Composed of IL-13 Antagonist and Pseudomonas Exotoxin
Mitomu Kioi; Koji Kawakami; Raj K. Puri
View articletitled, Analysis of Antitumor Activity of an Interleukin-13 (IL-13) Receptor-Targeted Cytotoxin Composed of IL-13 Antagonist and <strong><em>Pseudomonas</em></strong> Exotoxin
Open the PDF for in another window
Reversal of the Malignant Phenotype of Gastric Cancer Cells by Inhibition of RhoA Expression and Activity
Na Liu; Feng Bi; Yanglin Pan; Lijun Sun; Yan Xue; Yongquan Shi; Xuebiao Yao; Yi Zheng; Daiming Fan
View articletitled, Reversal of the Malignant Phenotype of Gastric Cancer Cells by Inhibition of RhoA Expression and Activity
Open the PDF for in another window
Enhancement of the Antibody-Dependent Cellular Cytotoxicity of Low-Fucose IgG1 Is Independent of FcγRIIIa Functional Polymorphism
Rinpei Niwa; Shigeki Hatanaka; Emi Shoji-Hosaka; Mikiko Sakurada; Yukari Kobayashi; Aya Uehara; Haruhiko Yokoi; Kazuyasu Nakamura; Kenya Shitara
View articletitled, Enhancement of the Antibody-Dependent Cellular Cytotoxicity of Low-Fucose IgG1 Is Independent of FcγRIIIa Functional Polymorphism
Open the PDF for in another window
Characterization of a Folate Transporter in HeLa Cells with a Low pH Optimum and High Affinity for Pemetrexed Distinct from the Reduced Folate Carrier
Yanhua Wang; Rongbao Zhao; I. David Goldman
View articletitled, Characterization of a Folate Transporter in HeLa Cells with a Low pH Optimum and High Affinity for Pemetrexed Distinct from the Reduced Folate Carrier
Open the PDF for in another window
Identification of the Fenretinide Metabolite 4-Oxo-Fenretinide Present in Human Plasma and Formed in Human Ovarian Carcinoma Cells through Induction of Cytochrome P450 26A1
Maria Grazia Villani; Valentina Appierto; Elena Cavadini; Manuela Valsecchi; Sandro Sonnino; Robert W. Curley; Franca Formelli
View articletitled, Identification of the Fenretinide Metabolite 4-Oxo-Fenretinide Present in Human Plasma and Formed in Human Ovarian Carcinoma Cells through Induction of Cytochrome P450 26A1
Open the PDF for in another window

Supplement Articles

Proceedings of the First International Conference
Innovations and Challenges in Renal Cancer: Consensus Statement from the First International Conference
Michael B. Atkins; David E. Avigan; Ronald M. Bukowski; Richard W. Childs; Janice P. Dutcher; Tim G. Eisen; Robert A. Figlin; James H. Finke; Robert C. Flanigan; Daniel J. George; S. Nahum Goldberg; Michael S. Gordon; Othon Iliopoulos; William G. Kaelin, Jr.; W. Marston Linehan; Allan Lipton; Robert J. Motzer; Andrew C. Novick; Walter M. Stadler; Bin Tean Teh; James C. Yang; Laura King
View articletitled, Innovations and Challenges in Renal Cancer<span class="subtitle-colon">: </span><span class="subtitle">Consensus Statement from the First International Conference</span>
Open the PDF for in another window
Genetic Basis of Cancer of the Kidney: Disease-Specific Approaches to Therapy
W. Marston Linehan; James Vasselli; Ramaprasad Srinivasan; McClellan M. Walther; Maria Merino; Peter Choyke; Cathy Vocke; Laura Schmidt; Jennifer S. Isaacs; Gladys Glenn; Jorge Toro; Berton Zbar; Donald Bottaro; Len Neckers
View articletitled, Genetic Basis of Cancer of the Kidney<span class="subtitle-colon">: </span><span class="subtitle">Disease-Specific Approaches to Therapy</span>
Open the PDF for in another window
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
William G. Kaelin, Jr.
View articletitled, The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
Open the PDF for in another window
Molecular Markers for Early Detection of Renal Carcinoma: Investigative Approach
Steven Skates; Othon Iliopoulos
View articletitled, Molecular Markers for Early Detection of Renal Carcinoma<span class="subtitle-colon">: </span><span class="subtitle">Investigative Approach</span>
Open the PDF for in another window
Prognostic Factors for Survival of Patients with Stage IV Renal Cell Carcinoma: Memorial Sloan-Kettering Cancer Center Experience
Robert J. Motzer; Jennifer Bacik; Madhu Mazumdar
View articletitled, Prognostic Factors for Survival of Patients with Stage IV Renal Cell Carcinoma<span class="subtitle-colon">: </span><span class="subtitle">Memorial Sloan-Kettering Cancer Center Experience</span>
Open the PDF for in another window
Tissue Array-Based Predictions of Pathobiology, Prognosis, and Response to Treatment for Renal Cell Carcinoma Therapy
John S. Lam; Arie S. Belldegrun; Robert A. Figlin
View articletitled, Tissue Array-Based Predictions of Pathobiology, Prognosis, and Response to Treatment for Renal Cell Carcinoma Therapy
Open the PDF for in another window
Prognostic Factors in Patients with Advanced Renal Cell Carcinoma: Development of an International Kidney Cancer Working Group
Ronald M. Bukowski; Sylvie Negrier; Paul Elson
View articletitled, Prognostic Factors in Patients with Advanced Renal Cell Carcinoma<span class="subtitle-colon">: </span><span class="subtitle">Development of an International Kidney Cancer Working Group</span>
Open the PDF for in another window
Gene Expression Profiling of Renal Cell Carcinoma
Min-Han Tan; Craig G. Rogers; Jeffrey T. Cooper; Jonathon A. Ditlev; Thomas J. Maatman; Ximing Yang; Kyle A. Furge; Bin Tean Teh
View articletitled, Gene Expression Profiling of Renal Cell Carcinoma
Open the PDF for in another window
Laparoscopic and Partial Nephrectomy
Andrew C. Novick
View articletitled, Laparoscopic and Partial Nephrectomy
Open the PDF for in another window
Review of Radiofrequency Ablation for Renal Cell Carcinoma
Andrew Hines-Peralta; S. Nahum Goldberg
View articletitled, Review of Radiofrequency Ablation for Renal Cell Carcinoma
Open the PDF for in another window
Debulking Nephrectomy in Metastatic Renal Cancer
Robert C. Flanigan
View articletitled, Debulking Nephrectomy in Metastatic Renal Cancer
Open the PDF for in another window
Update on the Role of Interleukin 2 and Other Cytokines in the Treatment of Patients with Stage IV Renal Carcinoma
Michael B. Atkins; Meredith Regan; David McDermott
View articletitled, Update on the Role of Interleukin 2 and Other Cytokines in the Treatment of Patients with Stage IV Renal Carcinoma
Open the PDF for in another window
Dendritic Cell-Tumor Fusion Vaccines for Renal Cell Carcinoma
David Avigan
View articletitled, Dendritic Cell-Tumor Fusion Vaccines for Renal Cell Carcinoma
Open the PDF for in another window
Nonmyeloablative Transplantation: An Allogeneic-Based Immunotherapy for Renal Cell Carcinoma
Yoshiyuki Takahashi; Richard W. Childs
View articletitled, Nonmyeloablative Transplantation<span class="subtitle-colon">: </span><span class="subtitle">An Allogeneic-Based Immunotherapy for Renal Cell Carcinoma</span>
Open the PDF for in another window
Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses
Patricia Rayman; Amy K. Wesa; Amy L. Richmond; Tanya Das; Kaushik Biswas; Gira Raval; Walter J. Storkus; Charles Tannenbaum; Andrew Novick; Ronald Bukowski; James Finke
View articletitled, Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses
Open the PDF for in another window
Bevacizumab for Patients with Metastatic Renal Cancer: An Update
James C. Yang
View articletitled, Bevacizumab for Patients with Metastatic Renal Cancer<span class="subtitle-colon">: </span><span class="subtitle">An Update</span>
Open the PDF for in another window
Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Anil Potti; Daniel J. George
View articletitled, Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Open the PDF for in another window
Novel Antiangiogenic Therapies for Renal Cell Cancer
Michael S. Gordon
View articletitled, Novel Antiangiogenic Therapies for Renal Cell Cancer
Open the PDF for in another window
Mammalian Target of Rapamycin Inhibition
Janice P. Dutcher
View articletitled, Mammalian Target of Rapamycin Inhibition
Open the PDF for in another window
Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
Tanya Ahmad; Tim Eisen
View articletitled, Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
Open the PDF for in another window
Therapeutic Options for Variant Renal Cancer: A True Orphan Disease
Walter M. Stadler
View articletitled, Therapeutic Options for Variant Renal Cancer<span class="subtitle-colon">: </span><span class="subtitle">A True Orphan Disease</span>
Open the PDF for in another window
Skeletal Complications in Patients with Bone Metastases from Renal Cell Carcinoma and Therapeutic Benefits of Zoledronic Acid
Allan Lipton; Alejandro Colombo-Berra; Ronald M. Bukowski; Lee Rosen; Ming Zheng; Gladys Urbanowitz
View articletitled, Skeletal Complications in Patients with Bone Metastases from Renal Cell Carcinoma and Therapeutic Benefits of Zoledronic Acid
Open the PDF for in another window
CME Assessment Test
View articletitled, CME Assessment Test
Open the PDF for in another window
Registration and Evaluation Form
View articletitled, Registration and Evaluation Form
Open the PDF for in another window

Advertisement

Latest News
Cancer Grand Challenges Throws Down Gauntlet
Aspirin Boosts Immune Response to Stop Cancer Spread
Clinicians Warn Trump’s EOs Will Harm LGBTQ+ Patients
View more recent articles
Breaking
DFCI Wins Approval for $1.7 Billion Hospital
Roche Inks Deal Worth up to $1 Billion Over ADCs
AstraZeneca to Buy Lentivirus-Focused Biotech
View more recent articles
Research Watch
Synonymous Mutations in m6A-modified Sites Can Destabilize Tumor Suppressors
MIF–ACKR3 Signaling Drives Cancer Cachexia by Impairing Adipogenesis
Epithelial-to-Mesenchymal Transition Supports Pancreatic Cancer Evolution
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept